Literature DB >> 18097637

Impact of vessel size on distal embolization, myocardial perfusion and clinical outcome in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction.

Giuseppe De Luca1, Harry Suryapranata, Menko-Jan de Boer, Jan Paul Ottervanger, Jan C A Hoorntje, A T Marcel Gosselink, Jan-Henk E Dambrink, Arnoud W J van't Hof.   

Abstract

BACKGROUND: Mounting interest has emerged on the role of distal embolization as a major explanation of poor myocardial perfusion among patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary angioplasty. The aim of the current study was to evaluate the relationship between vessel size, distal embolization, myocardial perfusion and clinical outcome in patients with STEMI treated by primary angioplasty.
METHODS: Our population is represented by 1969 patients with STEMI undergoing primary stenting from 1997 to 2002. All clinical, angiographic, and follow-up data were prospectively collected.
RESULTS: Vessel size was linearly associated with gender, diabetes, anterior infarction location, shorter time-delay, the rate of stenting and glycoprotein IIb-IIIa inhibitors. Small vessel size was associated with poor perfusion, despite lower rates of distal embolization. These data were confirmed after correction for confounding factors. The higher risk profile and poor myocardial perfusion contribute to explain the worse outcome observed in patients with smaller vessel size.
CONCLUSIONS: This study shows that in patients undergoing primary angioplasty for STEMI, small vessel size is associated with poor myocardial perfusion, despite less distal embolization, that contributes to explain the worse outcome observed among patients with small infarct related arteries.

Entities:  

Mesh:

Year:  2007        PMID: 18097637     DOI: 10.1007/s11239-007-0179-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  38 in total

1.  Influence of vessel size on early and late outcomes after primary angioplasty for acute myocardial infarction.

Authors:  B R Brodie; T D Stuckey; C Hansen; G Kissling; D Muncy
Journal:  J Invasive Cardiol       Date:  2000-01       Impact factor: 2.022

2.  Sex differences in coronary artery size assessed by intravascular ultrasound.

Authors:  S E Sheifer; M R Canos; K P Weinfurt; U K Arora; F O Mendelsohn; B J Gersh; N J Weissman
Journal:  Am Heart J       Date:  2000-04       Impact factor: 4.749

3.  Distal embolization during primary angioplasty: histopathologic features and predictability.

Authors:  Ugo Limbruno; Marco De Carlo; Sabina Pistolesi; Andrea Micheli; Anna Sonia Petronio; Tiziano Camacci; Gabriella Fontanini; Alberto Balbarini; Mario Mariani; Raffaele De Caterina
Journal:  Am Heart J       Date:  2005-07       Impact factor: 4.749

Review 4.  Microvascular dysfunction in acute myocardial infarction: focus on the roles of platelet and inflammatory mediators in the no-reflow phenomenon.

Authors:  A D Michaels; C M Gibson; H V Barron
Journal:  Am J Cardiol       Date:  2000-03-09       Impact factor: 2.778

5.  Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

Authors:  Gregg W Stone; John Webb; David A Cox; Bruce R Brodie; Mansoor Qureshi; Anna Kalynych; Mark Turco; Heinz P Schultheiss; Daniel Dulas; Barry D Rutherford; David Antoniucci; Mitchell W Krucoff; Raymond J Gibbons; Denise Jones; Alexandra J Lansky; Roxana Mehran
Journal:  JAMA       Date:  2005-03-02       Impact factor: 56.272

6.  A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

Authors:  C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis
Journal:  N Engl J Med       Date:  1993-03-11       Impact factor: 91.245

7.  Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals.

Authors:  H Komatsu; A Koo; E Ghadishah; H Zeng; J F Kuhlenkamp; M Inoue; P H Guth; N Kaplowitz
Journal:  Am J Physiol       Date:  1992-04

Review 8.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Is it possible to predict which patients need distal protection during primary angioplasty?

Authors:  Hisashi Umeda; Mitsunori Iwase; Hideo Izawa; Toshiaki Katoh; Tomoko Gochi; Junji Toyama; Masaki Yokoya; Toyoaki Matsushita; Ryoji Ishiki; Haruo Inagaki; Toyoaki Murohara; Mitsuhiro Yokota
Journal:  Int J Cardiol       Date:  2007-08-08       Impact factor: 4.164

10.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  4 in total

Review 1.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

Review 2.  Antithrombotic therapies in primary angioplasty: rationale, results and future directions.

Authors:  Giuseppe De Luca; Paolo Marino
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  Sex-Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation.

Authors:  Edina Cenko; Mihaela van der Schaar; Jinsung Yoon; Sasko Kedev; Marija Valvukis; Zorana Vasiljevic; Milika Ašanin; Davor Miličić; Olivia Manfrini; Lina Badimon; Raffaele Bugiardini
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

4.  The effectiveness and safety of the RESTORE® drug-eluting balloon versus a drug-eluting stent for small coronary vessel disease: study protocol for a multi-center, randomized, controlled trial.

Authors:  Yi-Da Tang; Shu-Bin Qiao; Xi Su; Yun-Dai Chen; Ze-Ning Jin; Hui Chen; Biao Xu; Xiang-Qing Kong; Wen-Yue Pang; Yong Liu; Zai-Xin Yu; Xue Li; Hui Li; Yan-Yan Zhao; Wei Li; Jian Tian; Chang-Dong Guan; Bo Xu; Run-Lin Gao
Journal:  J Geriatr Cardiol       Date:  2018-07       Impact factor: 3.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.